Down-regulation of VEGFA and TNF expression was observed after Celastrol treatment and was accompanied by a decrease in cell viability, suggesting that Celastrol may reverse the malignant phenotype of NPC cells by reducing their expressions. This evidence concerns the gene TNF and nasopharyngeal carcinoma.